167 related articles for article (PubMed ID: 1312683)
1. Plasmapheresis and antineoplastic treatment in CNS paraneoplastic syndromes with antineuronal autoantibodies.
Graus F; Vega F; Delattre JY; Bonaventura I; Reñé R; Arbaiza D; Tolosa E
Neurology; 1992 Mar; 42(3 Pt 1):536-40. PubMed ID: 1312683
[TBL] [Abstract][Full Text] [Related]
2. Clinical outcome of patients with anti-Hu-associated encephalomyelitis after treatment of the tumor.
Keime-Guibert F; Graus F; Broët P; Reñé R; Molinuevo JL; Ascaso C; Delattre JY
Neurology; 1999 Nov; 53(8):1719-23. PubMed ID: 10563618
[TBL] [Abstract][Full Text] [Related]
3. Small-cell lung cancer, paraneoplastic cerebellar degeneration and the Lambert-Eaton myasthenic syndrome.
Mason WP; Graus F; Lang B; Honnorat J; Delattre JY; Valldeoriola F; Antoine JC; Rosenblum MK; Rosenfeld MR; Newsom-Davis J; Posner JB; Dalmau J
Brain; 1997 Aug; 120 ( Pt 8)():1279-300. PubMed ID: 9278623
[TBL] [Abstract][Full Text] [Related]
4. Paraneoplastic cerebellar degeneration associated with antineuronal antibodies: analysis of 50 patients.
Shams'ili S; Grefkens J; de Leeuw B; van den Bent M; Hooijkaas H; van der Holt B; Vecht C; Sillevis Smitt P
Brain; 2003 Jun; 126(Pt 6):1409-18. PubMed ID: 12764061
[TBL] [Abstract][Full Text] [Related]
5. Treatment of paraneoplastic neurological syndromes with antineuronal antibodies (Anti-Hu, anti-Yo) with a combination of immunoglobulins, cyclophosphamide, and methylprednisolone.
Keime-Guibert F; Graus F; Fleury A; René R; Honnorat J; Broet P; Delattre JY
J Neurol Neurosurg Psychiatry; 2000 Apr; 68(4):479-82. PubMed ID: 10727484
[TBL] [Abstract][Full Text] [Related]
6. Intravenous immunoglobulin treatment in paraneoplastic neurological syndromes with antineuronal autoantibodies.
Uchuya M; Graus F; Vega F; Reñé R; Delattre JY
J Neurol Neurosurg Psychiatry; 1996 Apr; 60(4):388-92. PubMed ID: 8774401
[TBL] [Abstract][Full Text] [Related]
7. Steroid-dependent anti-Hu negative paraneoplastic encephalomyelitis and small cell lung carcinoma.
Arjona A; Castellanos F; Graus F; Sanchez P; Escamilla C; Pascual ML
J Neurol; 1998 Apr; 245(4):238-40. PubMed ID: 9591227
[No Abstract] [Full Text] [Related]
8. [Neurologic syndromes associated with anti-Hu antibody. Study of 24 patients].
Valldeoriola F; Vega F; Reñé R; Pou A; Roquer J; Delattre JY; Graus F
Med Clin (Barc); 1992 Oct; 99(10):361-4. PubMed ID: 1334171
[TBL] [Abstract][Full Text] [Related]
9. Autoantibodies in paraneoplastic syndromes associated with small-cell lung cancer.
Anderson NE; Rosenblum MK; Graus F; Wiley RG; Posner JB
Neurology; 1988 Sep; 38(9):1391-8. PubMed ID: 2842702
[TBL] [Abstract][Full Text] [Related]
10. Paraneoplastic cerebellar degeneration: a clinical comparison of patients with and without Purkinje cell cytoplasmic antibodies.
Hammack JE; Kimmel DW; O'Neill BP; Lennon VA
Mayo Clin Proc; 1990 Nov; 65(11):1423-31. PubMed ID: 2232897
[TBL] [Abstract][Full Text] [Related]
11. Effect of plasmapheresis on serum and CSF autoantibody levels in CNS paraneoplastic syndromes.
Graus F; Abos J; Roquer J; Mazzara R; Pereira A
Neurology; 1990 Oct; 40(10):1621-3. PubMed ID: 2215957
[TBL] [Abstract][Full Text] [Related]
12. [Importance of plasmapheresis in the treatment of paraneoplastic cerebellar degeneration].
Basić-Jukić N; Kes P; Basić-Kes V; Brunetta B
Acta Med Croatica; 2004; 58(1):63-6. PubMed ID: 15125396
[TBL] [Abstract][Full Text] [Related]
13. [Autoimmunity and paraneoplastic neurologic syndromes].
Delattre JY; Davila L; Vega F; Poisson M
Rev Neurol (Paris); 1991; 147(8-9):549-56. PubMed ID: 1962063
[TBL] [Abstract][Full Text] [Related]
14. Autoantibodies in neurological paraneoplastic diseases.
Lövblad KO; Boucraut J; Lehmann HP; Stahel R; Regli F; Steck AJ
Schweiz Arch Neurol Psychiatr (1985); 1994; 145(3):3-7. PubMed ID: 7533934
[TBL] [Abstract][Full Text] [Related]
15. Autoimmune paraneoplastic cerebellar degeneration in ovarian carcinoma patients treated with plasmapheresis and immunoglobulin. A case report.
David YB; Warner E; Levitan M; Sutton DM; Malkin MG; Dalmau JO
Cancer; 1996 Nov; 78(10):2153-6. PubMed ID: 8918408
[TBL] [Abstract][Full Text] [Related]
16. Absence of anti-P/Q calcium channel antibody in the sera of patients with anti-Yo antibody-positive paraneoplastic cerebellar degeneration.
Tanaka K; Motomura M; Nakao Y; Tanaka M; Tsuji S
Neurology; 1997 Sep; 49(3):895-6. PubMed ID: 9305368
[No Abstract] [Full Text] [Related]
17. [Immunobiological approach to spinocerebellar degeneration--anti-Purkinje cell antibodies in paraneoplastic cerebellar degeneration].
Miyatake T
Rinsho Shinkeigaku; 1993 Dec; 33(12):1291-3. PubMed ID: 8174327
[TBL] [Abstract][Full Text] [Related]
18. [Paraneoplastic cerebellar degeneration].
Chabriat H; Chen QM; Poisson M; Delattre JY
Rev Neurol (Paris); 1994; 150(2):105-14. PubMed ID: 7863150
[TBL] [Abstract][Full Text] [Related]
19. Clinical and pathological advances on central nervous system paraneoplastic syndromes.
Graus F; René R
Rev Neurol (Paris); 1992; 148(6-7):496-501. PubMed ID: 1448670
[TBL] [Abstract][Full Text] [Related]
20. Paraneoplastic encephalomyelitis. Dramatic response to chemotherapy alone.
Batson OA; Fantle DM; Stewart JA
Cancer; 1992 Mar; 69(5):1291-3. PubMed ID: 1310891
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
